Drug-induced pemphigus. II. Pathomechanisms and experimental investigations.
Ruocco
V
V
Department of Dermatology, School of Medicine, 2nd University of Naples, Italy.
De Angelis
E
E
Lombardi
M L
ML
D000051:Acantholysis / Q000139:chemically induced* / Q000201:enzymology / Q000473:pathology; D046508:Culture Techniques; D003875:Drug Eruptions / Q000209:etiology*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000378:metabolism; D006801:Humans; D015603:Keratinocytes / Q000201:enzymology; D010392:Pemphigus / Q000139:chemically induced*; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism; D012867:Skin / Q000187:drug effects / Q000473:pathology; D013438:Sulfhydryl Compounds / Q000009:adverse effects* / Q000494:pharmacology
D004791:Enzyme Inhibitors; D017395:Plasminogen Activator Inhibitor 1; D013438:Sulfhydryl Compounds; D010960:Plasminogen Activators